Riboflavin deficiency reduces bone mineral density in rats by compromising osteoblast function

Area of Science:

• Biochemistry
• Bone Biology
• Nutritional Science

Background:

• Riboflavin (vitamin B2) is essential for cellular metabolism.
• Insufficient riboflavin intake is linked to compromised bone health.

Purpose of the Study:

• To investigate the in vivo and in vitro effects of riboflavin deficiency on bone health.
• To elucidate the molecular mechanisms underlying riboflavin deficiency-induced bone impairment.

Main Methods:

• Established riboflavin deficiency in a rat model and osteoblast cell cultures.
• Assessed bone mineral density, serum markers, and protein expression (Runx2, Osterix, BMP-2/Smad1/5/9, p-p38 MAPK).
• Utilized SB203580 to block the p38 MAPK signaling pathway in cellular experiments.

Main Results:

• Riboflavin deficiency significantly decreased bone mineral density, bone alkaline phosphatase, phosphorus, and calcium in rats.
• Osteoblast activity, calcified nodule formation, and key bone formation proteins (Runx2, Osterix, BMP-2/Smad1/5/9) were reduced in deficient cells.
• Riboflavin deficiency increased p-p38 MAPK expression, which was reversed by SB203580, indicating its role in the pathway.

Conclusions:

• Riboflavin deficiency causes osteoblast dysfunction and hinders bone matrix mineralization.
• The p38 MAPK/BMP-2/Smad1/5/9 signaling pathway is implicated in riboflavin deficiency-induced bone impairment.
• Maintaining adequate riboflavin levels is crucial for preserving bone health.